Opko Cash And Cash Equivalents Changes from 2010 to 2024

OPK Stock  USD 1.58  0.02  1.28%   
Opko Health Cash And Cash Equivalents Changes yearly trend continues to be quite stable with very little volatility. Cash And Cash Equivalents Changes may rise above about 60.4 M this year. From the period between 2010 and 2024, Opko Health, Cash And Cash Equivalents Changes regression line of its data series had sample variance of 4352.3 T and sample variance of 4352.3 T. View All Fundamentals
 
Cash And Cash Equivalents Changes  
First Reported
2012-03-31
Previous Quarter
-43.5 M
Current Value
-2.4 M
Quarterly Volatility
66.7 M
 
Yuan Drop
 
Covid
Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 110.6 M, Interest Expense of 14.2 M or Total Revenue of 906.7 M, as well as many indicators such as Price To Sales Ratio of 1.25, Dividend Yield of 0.0011 or PTB Ratio of 0.78. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
  
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Latest Opko Health's Cash And Cash Equivalents Changes Growth Pattern

Below is the plot of the Cash And Cash Equivalents Changes of Opko Health over the last few years. It is Opko Health's Cash And Cash Equivalents Changes historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.
Cash And Cash Equivalents Changes10 Years Trend
Pretty Stable
   Cash And Cash Equivalents Changes   
       Timeline  

Opko Cash And Cash Equivalents Changes Regression Statistics

Arithmetic Mean14,609,205
Coefficient Of Variation451.58
Mean Deviation54,533,685
Median4,974,000
Standard Deviation65,971,819
Sample Variance4352.3T
Range247.3M
R-Value0.13
Mean Square Error4605.8T
R-Squared0.02
Significance0.64
Slope1,941,922
Total Sum of Squares60931.9T

Opko Cash And Cash Equivalents Changes History

202460.4 M
202357.5 M
202163.9 M
2020-13.9 M
2019-10.5 M
2018M
2017-77.2 M

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as Cash And Cash Equivalents Changes, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash And Cash Equivalents Changes57.5 M60.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.191
Earnings Share
(0.19)
Revenue Per Share
0.998
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.09)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.